Thiazolidinedione analogues for the treatment of hypertension

C - Chemistry – Metallurgy – 07 – D

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C07D 277/34 (2006.01) A61K 31/425 (2006.01) A61P 9/12 (2006.01)

Patent

CA 2699289

The present invention relates to thiazolidinedione analogues that are useful for treating hypertension, diabetes, and inflammatory diseases. Formula (I), wherein: each of R1 and R4 is independently selected from H, halo, aliphatic, and alkoxy, wherein the aliphatic and alkoxy are optionally substituted with 1-3 of halo; R2 is halo, hydroxy, or optionally substituted aliphatic, and R'2 is H, or R2 and R'2 together form oxo; R3 is H; and Ring A is a phenyl.

La présente invention concerne des analogues de thiazolidinedione représentés par la formule (I) qui sont utiles pour le traitement de l'hypertension, du diabète et des maladies inflammatoires. Dans la formule (I), chacun de R1 et R4 est sélectionné indépendamment dans le groupe constitué par H, halo, aliphatique et alcoxy, aliphatique et alcoxy étant éventuellement substitué par 1-3 de halo; R2 représente halo, hydroxy, ou éventuellement aliphatique substitué, et R'2 représente H, ou R2 et R'2 forment ensemble oxo; R3 représente H; et un cycle A représente un phényle.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Thiazolidinedione analogues for the treatment of hypertension does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Thiazolidinedione analogues for the treatment of hypertension, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Thiazolidinedione analogues for the treatment of hypertension will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1459644

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.